"COVID Toes" After mRNA COVID-19 Vaccines
J Allergy Clin Immunol Pract
.
2021 Aug;9(8):3196-3197.
doi: 10.1016/j.jaip.2021.05.030.
Epub 2021 Jun 20.
Authors
John M Kelso
1
,
Alvin B Coda
2
,
Richard M Keating
3
,
Dana M Vaccari
4
Affiliations
1
Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, Calif. Electronic address: kelso.john@scrippshealth.org.
2
Department of Dermatology, Scripps Clinic, San Diego, Calif.
3
Division of Rheumatology, Scripps Clinic, San Diego, Calif.
4
Department of Internal Medicine, Scripps Clinic, San Diego, Calif.
PMID:
34162525
PMCID:
PMC8214806
DOI:
10.1016/j.jaip.2021.05.030
No abstract available
MeSH terms
COVID-19 Vaccines*
COVID-19*
Humans
RNA, Messenger
SARS-CoV-2
Toes
Substances
COVID-19 Vaccines
RNA, Messenger